Korea fines 32 vaccine companies for bid rigging

GlaxoSmithKline and 31 other companies in the vaccine sector are facing fines of €28.6 million from Korea’s Fair Trade Commission for rigging bids to supply the government’s National Immunisation Programme.

Unlock unlimited access to all Global Competition Review content